Oscar Corsi

Oscar Corsi

Auto-generated profile, based on publicly available information

Oscar Corsi

Department of Gastroenterology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2023 in Journal of Hepatology
Verified
Journal Article
Open access
LDLuis Antonio Díaz
Luis Antonio Díaz
EFEduardo Fuentes-Lopez
Eduardo Fuentes-Lopez
FIFrancisco Idalsoaga
Francisco Idalsoaga
GAGustavo Ayares
Gustavo Ayares
OCOscar Corsi
Oscar Corsi
JAJuan Pablo Arab
Juan Pablo Arab
The long-term impact of alcohol-related public health policies (PHPs) on disease burden is unclear. We aimed to assess the association between alcohol-related PHPs and alcohol-related health consequences. We conducted an ecological multi-national study including 169 countries. We collected data on alcohol-related PHPs from the WHO Global Information System of Alcohol and Health 2010. Data on alcohol-related health consequences between 2010-2019 were obtained from the Global Burden of Disease database. We classified PHPs into five items, including criteria for low, moderate, and strong PHP establishment. We estimated an alcohol preparedness index (API) using multiple correspondence analysis (0 lowest and 100 highest establishment). We estimated an incidence rate ratio (IRR) for outcomes according to API using adjusted multilevel generalized linear models with a Poisson family distribution. The median API in the 169 countries was 54 [IQR 34.9-76.8]. The API was inversely associated with alcohol use disorder (AUD) prevalence (IRR 0.13; 95% CI 0.03-0.60; p = 0.010), alcohol-associated liver disease (ALD) mortality (IRR 0.14; 95% CI 0.03-0.79; p = 0.025), mortality due to neoplasms (IRR 0.09; 95% CI 0.02-0.40; p = 0.002), alcohol-attributable hepatocellular carcinoma (HCC) (IRR 0.13; 95% CI 0.02-0.65; p = 0.014), and cardiovascular diseases (IRR 0.09; 95% CI 0.02-0.41; p = 0.002). The highest associations were observed in the Americas, Africa, and Europe. These associations became stronger over time, and AUD prevalence was significantly lower after 2 years, while ALD mortality and alcohol-attributable HCC incidence decreased after 4 and 8 years from baseline API assessment, respectively (p <0.05). The API is a valuable instrument to quantify the robustness of alcohol-related PHP establishment. Lower AUD prevalence and lower mortality related to ALD, neoplasms, alcohol-attributable HCC, and cardiovascular diseases were observed in countries with a higher API. Our results encourage the development and strengthening of alcohol-related policies worldwide. We first developed an alcohol preparedness index, an instrument to assess the existence of alcohol-related public policies for each country. We then evaluated the long-term association of the country's alcohol preparedness index in 2010 with the burden of chronic liver disease, hepatocellular carcinoma, other neoplasms, and cardiovascular disease. The strengthening of alcohol-related public health policies could impact long-term mortality rates from cardiovascular disease, neoplasms, and liver disease. These conditions are the main contributors to the global burden of disease related to alcohol use. Over time, this association has not only persisted but also grown stronger. Our results expand the preliminary evidence regarding the importance of public health policies in controlling alcohol-related health consequences.

16 June 2021 in Hepatology
Verified
Journal Article
Closed access
PDF file
LDLuis Antonio Díaz
Luis Antonio Díaz
FIFrancisco Idalsoaga
Francisco Idalsoaga
EFEduardo Fuentes-Lopez
Eduardo Fuentes-Lopez
AMAndrea Márquez‐Lomas
Andrea Márquez‐Lomas
CRCarolina A. Ramírez
Carolina A. Ramírez
JAJuan Pablo Arab
Juan Pablo Arab

26 December 2023 in Gut
Verified
Journal Article
Closed access
PDF file
GLGonzalo Latorre
Gonzalo Latorre
FSFelipe Silva
Felipe Silva
IMIsabella Montero
Isabella Montero
MBMiguel Bustamante
Miguel Bustamante
EDEitan Dukes
Eitan Dukes
ARArnoldo Riquelme
Arnoldo Riquelme

29 March 2017 in Medwave
Verified
Journal Article
Open access
RMRodrigo Meza
Rodrigo Meza
JPJavier Peña
Javier Peña
KGKaren García
Karen García
OCOscar Corsi
Oscar Corsi
GRGabriel Rada
Gabriel Rada
Resumen\ud En el último tiempo, se han descrito diversos beneficios con el uso de cannabinoides en diferentes situaciones clínicas. Dentro de ellas se ha planteado un posible efecto en el control de la esclerosis múltiple, pero la real utilidad clínica es tema de debate. Para responder a esta pregunta utilizamos la base de datos Epistemonikos, la cual es mantenida mediante búsquedas en múltiples bases de datos. Identificamos 25 revisiones sistemáticas que en conjunto incluyen 35 estudios que responden la pregunta de interés, entre ellos 26 estudios aleatorizados. Extrajimos los datos, realizamos un metanálisis y preparamos una tabla de resumen de los resultados utilizando el método GRADE. Concluimos que el uso de cannabinoides en esclerosis múltiple no reduce la espasticidad ni el dolor, y probablemente se asocia a efectos adversos frecuentes

6 June 2017 in Medwave
Verified
Journal Article
Open access
YPYazmín Pinos
Yazmín Pinos
MRMaría Isabel Ruiz
María Isabel Ruiz
ÓCÓscar Corsi
Óscar Corsi
GRGabriel Rada
Gabriel Rada
Travelers' diarrhea is a frequent condition, especially in those traveling to high-risk areas. Although antibiotic treatment reduces the duration of diarrhea, it has been suggested adding loperamide could further reduce the symptoms. To answer this question we used Epistemonikos, the largest database of systematic reviews in health, which is maintained by screening multiple information sources, including MEDLINE, EMBASE, Cochrane, among others. We identified two systematic reviews including 28 studies overall, of which 15 were randomized trials relevant for the question of interest. We extracted data from the systematic reviews, reanalysed data of primary studies and generated a summary of findings table using the GRADE approach. We concluded adding loperamide to antibiotic treatment might accelerate resolution of symptoms in traveler’s diarrhea with minimal or no adverse effects.

1 October 2021 in Revista chilena de infectología
Verified
Journal Article
Open access
PDF file
TRTomás Reyes-Barros
Tomás Reyes-Barros
JUJavier Uribe-Monasterio
Javier Uribe-Monasterio
VGVicente Gándara-Fuenzalida
Vicente Gándara-Fuenzalida
FPFrancisca Pinochet-Valenzuela
Francisca Pinochet-Valenzuela
TYTatiana Yáñez-Ferrada
Tatiana Yáñez-Ferrada
ÓCÓscar Corsi-Soteo
Óscar Corsi-Soteo
Palabras clave: Elizabethkingia meningoseptica; Elizabethkingia anophelis; Flavobacteriaceae; infección asociada a atención de salud; control de infecciones intrahospitalarias; coinfecciones SARS-CoV-2